Pfizer's COVID Vaccine for Kids Under 5 , Moves Closer to FDA Approval .
Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.
Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete.
The three-dose vaccine is for children between the ages of six months and five years.
Pfizer released a statement detailing the application.
Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News.
... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News.
... for children 6 months through 4 years of age (also referred to as 6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News.
Pfizer reported an 80 percent effectiveness rate in children in May.
The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application.
We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News.
... and while the FDA cannot predict how long its evaluation of the data and information will take, , FDA Statement, via ABC News.
... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News.
According to a poll conducted by the Kaiser Family Foundation in April of this year.
... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved.
27 percent of parents stated that they will "definitely not" vaccinate their children against COVID
